![Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser](https://dermsinica.org/articles/2022/40/1/images/DermatolSin_2022_40_1_50_341353_f1.jpg)
Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser
![Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1ae7dfe5-6423-4a4f-b5a8-0302815e8802/ijd_3852_f1.gif)
Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo - Xu - 2009 - International Journal of Dermatology - Wiley Online Library
![Facial hypopigmentation in skin of color: An atypical presentation of lichen nitidus - Polcari - 2021 - Pediatric Dermatology - Wiley Online Library Facial hypopigmentation in skin of color: An atypical presentation of lichen nitidus - Polcari - 2021 - Pediatric Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1239920c-0074-47ce-a42b-d3ac4adf68ac/pde14692-fig-0001-m.jpg)
Facial hypopigmentation in skin of color: An atypical presentation of lichen nitidus - Polcari - 2021 - Pediatric Dermatology - Wiley Online Library
![Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser](https://dermsinica.org/articles/2022/40/1/images/DermatolSin_2022_40_1_50_341353_f2.jpg)
Laser-induced mottled hypopigmentation successfully treated with a combined regimen of topical calcineurin inhibitors and fractional CO<sub>2</sub> laser
![Comparison between the efficacy of microneedling combined with 5‐fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo - Mina - 2018 - Journal of Cosmetic Dermatology - Wiley Online Library Comparison between the efficacy of microneedling combined with 5‐fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo - Mina - 2018 - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e9e15b8-e0cc-45b2-8dc0-a48834be7ff2/jocd12440-fig-0005-m.jpg)
Comparison between the efficacy of microneedling combined with 5‐fluorouracil vs microneedling with tacrolimus in the treatment of vitiligo - Mina - 2018 - Journal of Cosmetic Dermatology - Wiley Online Library
![A, Exfoliative cheilitis. Patient 2 before beginning excimer therapy,... | Download Scientific Diagram A, Exfoliative cheilitis. Patient 2 before beginning excimer therapy,... | Download Scientific Diagram](https://www.researchgate.net/publication/277927950/figure/fig2/AS:269694682791946@1441311631459/A-Exfoliative-cheilitis-Patient-2-before-beginning-excimer-therapy-demonstrating.png)
A, Exfoliative cheilitis. Patient 2 before beginning excimer therapy,... | Download Scientific Diagram
![Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients](https://www.spandidos-publications.com/article_images/etm/15/4/etm-15-04-3981-g00.jpg)
Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients
![Tacrolimus-Induced Rosacea-Like Dermatitis: A Clinical Analysis of 16 Cases Associated with Tacrolimus Ointment Application | Semantic Scholar Tacrolimus-Induced Rosacea-Like Dermatitis: A Clinical Analysis of 16 Cases Associated with Tacrolimus Ointment Application | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c2d94f8e9933324bae4e6f133e5221a1cb854992/2-Figure1-1.png)
Tacrolimus-Induced Rosacea-Like Dermatitis: A Clinical Analysis of 16 Cases Associated with Tacrolimus Ointment Application | Semantic Scholar
![Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars | MDedge Dermatology Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/Nguyen_Microneedling_1.jpg)
Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars | MDedge Dermatology
![Localised hypopigmentation: clarification of a diagnostic conundrum | British Journal of General Practice Localised hypopigmentation: clarification of a diagnostic conundrum | British Journal of General Practice](https://bjgp.org/content/bjgp/68/674/444/F1.large.jpg?width=800&height=600&carousel=1)
Localised hypopigmentation: clarification of a diagnostic conundrum | British Journal of General Practice
![PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram](https://www.researchgate.net/publication/224940533/figure/fig1/AS:302874681724929@1449222359380/PA-lesion-treated-with-01-tacrolimus-ointment-in-a-7-year-old-boy-onset-and-8-weeks.png)
PA lesion treated with 0.1% tacrolimus ointment in a 7-year-old boy:... | Download Scientific Diagram
![Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba](https://static-02.hindawi.com/articles/drp/volume-2012/303275/figures/303275.fig.004.jpg)
Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
![The efficacy, safety, and stability of tacrolimus 0.03% ointment in treatment of nonsegmental vitiligo AbdElazim NE, Yassa HA, Mahran AM - J Curr Med Res Pract The efficacy, safety, and stability of tacrolimus 0.03% ointment in treatment of nonsegmental vitiligo AbdElazim NE, Yassa HA, Mahran AM - J Curr Med Res Pract](https://www.jcmrp.eg.net/articles/2020/5/1/images/JCurrMedResPract_2020_5_1_41_277499_f1.jpg)
The efficacy, safety, and stability of tacrolimus 0.03% ointment in treatment of nonsegmental vitiligo AbdElazim NE, Yassa HA, Mahran AM - J Curr Med Res Pract
![Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba](https://static-02.hindawi.com/articles/drp/volume-2012/303275/figures/303275.fig.003.jpg)
Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
![Different methods of enhancing the efficacy of topical tacrolimus in extra‐facial vitiligo: A comparative study - Esmat - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library Different methods of enhancing the efficacy of topical tacrolimus in extra‐facial vitiligo: A comparative study - Esmat - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/aacd717a-0c99-434e-af44-48376bbd6d06/jocd14024-fig-0004-m.jpg)
Different methods of enhancing the efficacy of topical tacrolimus in extra‐facial vitiligo: A comparative study - Esmat - 2021 - Journal of Cosmetic Dermatology - Wiley Online Library
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure6.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology](https://jcadonline.com/wp-content/uploads/ShahFeb2020Figure8.jpg)
Safety and Efficacy of the Combination of 308-nm Monochromatic Excimer Light and Topical 0.1% Tacrolimus Ointment in Segmental Vitiligo: An Open-label Study – JCAD | The Journal of Clinical and Aesthetic Dermatology
![Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate](https://d2ogjlfjkptkow.cloudfront.net/contentimage/21400.jpg)
Treatment Outcomes of Topical Calcineurin Inhibitor Therapy for Patients With Vitiligo | PracticeUpdate
![Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars | MDedge Dermatology Microneedling With Bimatoprost to Treat Hypopigmented Skin Caused by Burn Scars | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/CT111001031_e_Fig2_ABCD.jpg)